Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

After hours: March 10 at 7:55:58 PM EDT Loading Chart for BBD ...

After hours: March 13 at 7:59:12 PM EDT Loading Chart for NVO ...

Banco Products (India) Ltd. key Products/Revenue Segments include Aluminium Radiators, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...